AACR 2018: Positive data announced for KEYTRUDA® in adjuvant melanoma
Positive late-stage data has been announced from the KEYNOTE-054 trial, investigating KEYTRUDA® (pembrolizumab) in high-risk stage III melanoma patients.
Browsing: adjuvant
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer
Discover cases studies of rare recurrences after adjuvant chemotherapy in this Editorial from Future Oncology.
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1
In this research article find out how researchers developed a prognostic score for primary breast cancer patients integrating conventional predictors and the novel biomarker CHAC1 to aid adjuvant chemotherapy decisions.
Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
In this editorial find out about the promises and limitations of gemcitabine monotherapy as an adjuvant chemotherapy in pancreatic adenocarcinoma.
Vaccine therapy + dasatinib for the treatment of patients with stage IIIB–IV melanoma
In this from editorial Melanoma Management the authors explore the use of vaccines in combination with dasatinib for the treatment of stage IIIB–IV melanoma.
Optimizing adjuvant therapy and survivorship care of stage III colon cancer
Explore the current status of adjuvant treatment of colon cancer, and explore the potential of circulating tumor cells and DNA in disease surveillance in this article from Future Oncology.
The role of radiation therapy in the management of cutaneous melanoma
This article discusses the indications for adjuvant radiotherapy in melanoma, in terms of both the primary site and lymph node regions.
The challenge of managing adrenocortical carcinoma: two case studies
Read more about two cases of adrenocortical carcinoma and their management in light of clinical trial results supporting the use of adrenalytic mitotane as adjuvant therapy and a three-drug chemotherapy combination in the metastatic setting.
